宏中药业 (833746.OC)

+ 收藏

现金流量表(宏中药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 42,533,195.9687,899,979.1853,915,741.3745,712,719.7118,401,626.27
 收到的税费返还(元) 1,359,122.636,661,684.884,600,451.993,817,775.902,550,388.37
 收到其他与经营活动有关的现金(元) 836,722.4910,887,814.299,589,639.084,948,745.04442,629.03
 经营活动现金流入小计(元) 44,729,041.08105,449,478.3568,105,832.4454,479,240.6521,394,643.67
 购买商品、接受劳务支付的现金(元) 14,922,288.2122,301,630.6617,015,116.4511,772,364.335,786,949.63
 支付给职工以及为职工支付的现金(元) 13,804,785.2223,215,249.6517,062,219.2211,452,379.195,259,166.20
 支付的各项税费(元) 2,381,519.918,592,376.136,632,826.585,120,647.021,288,020.81
 支付其他与经营活动有关的现金(元) 5,114,951.5412,594,562.9310,193,880.135,690,960.892,289,976.26
 经营活动现金流出小计(元) 36,223,544.8866,703,819.3750,904,042.3834,036,351.4314,624,112.90
 经营活动产生的现金流量净额(元) 8,505,496.2038,745,658.9817,201,790.0620,442,889.226,770,530.77
二、投资活动产生的现金流量
 收到其他与投资活动有关的现金(元) 2,700,000.002,000,000.00---
 投资活动现金流入小计(元) 2,700,000.002,000,000.00---
 购建固定资产、无形资产和其他长期资产支付的现金(元) 14,230,722.4348,362,270.5743,330,391.2032,115,238.9214,893,800.15
 投资支付的现金(元) -75,000.0075,000.00--
 支付其他与投资活动有关的现金(元) -4,700,000.004,700,000.002,000,000.00-
 投资活动现金流出小计(元) 14,230,722.4353,137,270.5748,105,391.2034,115,238.9214,893,800.15
 投资活动产生的现金流量净额(元) -11,530,722.43-51,137,270.57-48,105,391.20-34,115,238.92-14,893,800.15
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 47,500,000.0062,700,000.0069,200,000.0051,200,000.0027,500,000.00
 收到其他与筹资活动有关的现金(元) ---300,000.00--
 筹资活动现金流入小计(元) 47,500,000.0062,700,000.0068,900,000.0051,200,000.0027,500,000.00
 偿还债务支付的现金(元) 28,500,000.0039,500,000.0034,000,000.0029,000,000.009,800,000.00
 分配股利、利润或偿付利息支付的现金(元) 10,505,527.797,088,275.786,732,254.936,374,972.81237,905.54
 支付其他与筹资活动有关的现金(元) -3,674,000.00---
 筹资活动现金流出小计(元) 39,005,527.7950,262,275.7840,732,254.9335,374,972.8110,037,905.54
 筹资活动产生的现金流量净额(元) 8,494,472.2112,437,724.2228,167,745.0715,825,027.1917,462,094.46
四、汇率变动对现金及现金等价物的影响(元) 573,772.67148,996.99-232,583.69-290,821.51-158,047.38
五、现金及现金等价物净增加额(元) 6,043,018.65195,109.62-2,968,439.761,861,855.989,180,777.70
 加:期初现金及现金等价物余额(元) 6,854,823.706,659,714.086,659,714.086,659,714.086,659,714.08
 期末现金及现金等价物余额(元) 12,897,842.356,854,823.703,691,274.328,521,570.0615,840,491.78
补充资料:
 净利润(元) 10,989,514.6844,546,181.02-20,045,333.63-
 资产减值准备(元) 678,198.681,392,588.00-149,913.58-
 固定资产和投资性房地产折旧(元) 5,242,395.628,462,068.26-3,773,103.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 5,242,395.628,462,068.26-3,773,103.17-
 无形资产摊销(元) 52,900.7383,903.16-41,951.58-
 固定资产报废损失(元) 16,384.511,282.05---
 财务费用(元) 181,223.73825,471.88-832,254.28-
 投资损失(元) 22,847.63257,333.40-172,445.32-
 递延所得税(元) 117,300.5582,316.33-122,942.23-
  其中:递延所得税资产减少(元) 117,300.5582,316.33-122,942.23-
 存货的减少(元) -9,346,288.25-5,758,189.90--5,739,329.59-
 经营性应收项目的减少(元) 2,592,731.80-15,586,152.37--983,713.38-
 经营性应付项目的增加(元) -2,944,694.882,632,786.04-1,124,898.69-
 其他(元) 902,981.401,806,071.11-903,089.71-
 现金的期末余额(元) 12,897,842.356,854,823.70-8,521,570.06-
 减:现金的期初余额(元) 6,854,823.706,659,714.08-6,659,714.08-
 现金及现金等价物的净增加额(元) 6,043,018.65195,109.62-1,861,855.98-
公告日期 2024-08-262024-02-202023-10-162023-08-282023-05-26
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院